Cite
HARVARD Citation
Crowell, T. et al. (2019). Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 6 (5), pp. e297-e306. [Online].